CURANUM AG

EANS-Adhoc: CURANUM AG
Changes to the Chairmanship of the Management Board of CURANUM AG

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Company Information/Changes to the Chairmanship of the Management Board of CURANUM AG

03.09.2010

Unscheduled announcement

Changes to the Chairmanship of the Management Board of CURANUM AG

CURANUM AG, Munich, announces that the Supervisory Board has today removed Mr. Bernd Rothe from his position as Chairman of the Management Board (CEO), and has also removed him from the Management Board with immediate effect, as well as relieving him from all duties within the Group.

The Supervisory Board plans to appoint and announce his successor within the next weeks. Until then, Mr. Rothe's duties will be exercised by Management Board members Mrs. Judith Barth (CFO) and Mrs. Sabine Weirich (COO).

Munich, September 3, 2010

The Management Board

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Bettina Pöschl
Tel. +49(0)89-242065-69
E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN:      DE0005240709
WKN:        524070
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / regulated dealing



Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: